- Despite Previous Data, Paxlovid May Be Useful for Long Covid After All
- Some GLP-1s Achieve More Weight Loss Than Others: Study
- More Evidence Bolsters the Oral Herpes and Alzheimer’s Link
- Health Advocates Are Unhappy with FDA Guidance on Lead Levels in Baby Food
- FDA Calls for Better Accuracy of Pulse Oximeters in People of Color
- Fluoride May Be Linked to Decreased IQ, Says “Limited Data,” Hard-to-Interpret Study
- First U.S. Death From Bird Flu Reported in Louisiana
- Blood Test May Help Predict How Long Immunity Lasts
- DoxyPEP Lowers Rate of Sexually Transmitted Infections (STIs), Data Suggests
- Multilingual Children with Autism Show Improved Cognitive Function
Pfizer Says Omicron-Specific Vaccine Ready by March
Pfizer Inc. said Tuesday that a COVID-19 vaccine that specifically targets the Omicron variant will be ready by March.
The company has already started making the new version of the vaccine, Pfizer CEO Albert Bourla told CNBC‘s “Squawk Box,” CBS News reported.
Omicron now accounts for more than 98% of all new COVID-19 cases in the United States, according to the U.S. Centers for Disease Control and Prevention.
Pfizer is also working to improve its current COVID-19 vaccine “to address any future variant of potential concern, if needed,” a company spokesperson said in a statement to CBS MoneyWatch.
“In the event that a third dose with the current vaccine is not found to protect against the Omicron variant or other future variants, Pfizer expects to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval,” the spokesperson added.
Also on Monday, Moderna said in a statement that it’s also developing an Omicron-specific vaccine, CBS News reported.
“Given the long-term threat demonstrated by Omicron’s immune escape, Moderna will continue to develop an Omicron-specific variant vaccine that it expects to advance into clinical trials in early 2022,” the company stated.
In the meantime, booster shots remain the best defense against Omicron, experts said.
In December, White House chief medical adviser Dr. Anthony Fauci predicted that Omicron would become the dominant virus strain in the United States but he has not said that a new Omicron-specific shot is necessary to maintain immunity. Instead, he has urged Americans to get booster shots, which studies have started to show provide the best protection against Omicron.
A recent study from the U.K. Health Security Agency found that booster shots are up to 75% effective at preventing symptomatic COVID-19 infection caused by Omicron.
More information
Visit the U.S. Food and Drug Administration for more on COVID vaccines.
SOURCES: Moderna Inc., news release, Jan. 10, 2022; CBS News
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Estrogen May Trigger Binge Drinking, Prelim Study SuggestsA woman’s binge drinking might be related to her...
- December 31, 2024
-
Some Abortion Pill Users Surprised By Pain, Study SaysAbortion pills are safe and effective, but some pain...
- December 20, 2024
-
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box WarningThe U.S. Food and Drug Administration (FDA) has issued...
- December 18, 2024
-
Non-heterosexual Women Report Better Sexual Functioning During Midlife
TUESDAY, Dec. 17, 2024 A woman’s sex drive often...
- December 18, 2024
